about
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports me...
Read More
7.00
0.52
(8.02%)
2.2M
XNAS Volume
High volume+gain today
XNAS 08 Jul, 2025 5:30 PM (EDT)
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest.
View Similar
Embed DVM
Mimedx Group Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..